C

Cellectis SA
D

CLLS

1.87000
USD
0.01
(0.54%)
Market Open
Volume
100
EPS
-1
Div Yield
-
P/E
-2
Market Cap
187,175,543
OverviewSignalsIdeasNews
Related Instruments
    A
    ALLO
    -0.19000
    (-7.71%)
    2.27500 USD
    B
    BEAM
    -2.275
    (-8.65%)
    24.035 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    F
    FATE
    -0.04500
    (-2.17%)
    2.02500 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    N
    NTLA
    -1.165
    (-7.71%)
    13.955 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    452.43 USD
    More
News

Title: Cellectis SA

Sector: Healthcare
Industry: Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.